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Abstract
The aging of the population results in a rise of 
number of elderly patients (aged 80 years and older) 
with pancreatic or periampullary cancer, and more 
pancreatectomies could eventually be performed in 
such complex patients. However, early and long-term 
results after pancreatic resection in octogenarians are 
still controversial, and may trouble the surgeon when 
approaching this type of population. Evaluation of 
reported experiences shows that for almost all Authors, 
pancreatectomy can be performed safely in elderly 
population, although overall morbidity and mortality 
rates were 34.9% and 13.2% respectively, with a mean 
length of hospital stay of 18 d. These features appear 
higher in older patients compared to the younger 
counterpart. Less than 50% of patients underwent 
adjuvant therapy after operation. Long-term survival 
is reported not significantly different in aged 80 years 
and older patients, with a median overall survival time 
of 17.6 mo. The quality of life after pancreatic resection 
is only sporadically evaluated but, when considered, 
it highlights the need of health facility service after 
operation for these “frail” patients. Prospective studies 
on the quality of life of pancreatectomized octogen-
arians are welcome. Proper selection of patients, 
geriatric assessment with multidisciplinary approach, 
centralization of pancreatic surgery in high-volume 
centres and rehabilitation programs after surgery 
appear to be crucial points in order to improve surgical 
treatments of pancreatic tumors in very elderly patients. 
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Core tip: Although not statistically significant, pancrea-
tic resection in very older patients carried a greater risk 
of complications, mortality and nursing facility after 
discharge than in younger patients. Thus, pancreatec-
tomy in 80 years and older patients, should be performed 
after careful consideration of potential benefit, surgical 
risk, and patient’s preferences.
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INTRODUCTION
The number of elderly in Western countries is rapidly 
increasing and it constitutes the fastest-growing age 
group of the population[1]. In the United States, the 
proportion of people 65 years of age or older will reach 
18.2% by 2025[2], and the oldest elderly (individuals 
85 years old or older) will account for 5% of the overall 
population[3]. The number of octogenarian patients 
referred to surgeons is going to gradually increase as 
well. This is particularly true for gastrointestinal cancers, 
which are characterized by the greatest incidence in 
the elderly, pancreatic cancer included. In past years, 
the high mortality and morbidity rates associated with 
pancreatic resections made this kind of surgery a rare 
indication for elderly people, considering also the limited 
survival time associated with pancreatic cancer. Recent 
data have clearly shown that pancreatic surgery is safe 
and feasible in high-volume centres, with reported 
mortality rates less than 2% and acceptable morbidity 
rates[4,5]. As postoperative outcome after pancreatic 
resections improved, many authors began to report 
pancreatectomies also in elderly patients. However, 
there are limited data on outcomes in octogenarians 
patients after pancreatic surgery. So, some crucial 
points may arise when treating very elderly patients 
with pancreatic tumors: (1) Is pancreatic resection 
safe and feasible in octogenarians? (2) Is surgical 
risk justified by long-term outcome after resection of 
malignancy? (3) Is quality of life preserved after major 
pancreatic resection?
The aim of this study was to analyse the existing 
literature and the available data on early postoperative 
outcomes and long-term results after pancreatic 
resection in patients 80 years and older. 
EVIDENCE ACQUISITION
The published Literature was systematically searched 
using PubMed and free text search engines up to 
December 2015. The following search terms were used: 
Pancreaticoduodenectomy, pancreatectomy, duodenal 
neoplasm/surgery, pancreatic neoplasm/surgery, 
pancreatic neoplasm/surgery, 80 years of age and over, 
elderly and octogenarian. The “related articles” function 
was used to broaden the search and all abstracts, 
studies, and citations retrieved were reviewed. The 
preliminary literature search showed 113 studies 
matching the initial criteria. After screening, 16 studies 
evaluating octogenarians patients and their outcome 
after pancreatic resections were selected[2,3,6-19]. 
Information about 3793 aged 80-years or older patients 
who underwent pancreatic resections, were collected 
(Table 1). There were 13 single institution’s series, 2 
nation or regional inpatient samples, and 1 multicentric 
report. In the population selected, there were 1710 
male patients (45.1%) and the mean age was 82.2 
years. Information about preoperative comorbidities 
were available for 489 patients. The most frequent 
reported comorbidities were cardiovascular disease 
(53.8%, n = 263 patients), in particular hypertension 
was reported for 168 patients, and coronary disease for 
95 patients. Other frequent major comorbidities were 
diabetes mellitus (n = 94, 19.2%), pulmonary disease 
(n = 30, 6.1%) and chronic renal failure (n = 10, 2.0%). 
Elderly patients are often reported to have two or more 
concomitant major comorbidities. Finlayson et al[8] and 
Khan et al[11] reported a percentage of respectively 
67.6% and 51% patients with 2 or more concomitant 
diseases. Six studies[3,11,14-16,18] reported data on the 
American Society of Anesthesiologists (ASA) score, with 
ASA grades 3 or 4 more frequently observed (60.3% of 
patients) (Table 2).
SURGERY
Thirteen studies[2,3,6,7,10-16,18,19] reported the type of 
pancreatic neoplasm treated (n = 626 patients). In 
particular, four reports evaluated only outcome after 
resections for pancreatic adenocarcinoma, whereas 
other two authors considered also patients with other 
primary malignancies. Finally, the remaining 7 studies 
addressed also resections for benign pancreatic 
conditions. Malignant indications for surgery accounted 
for 89.8% of cases (n = 562), with pancreatic 
adenocarcinoma being the most frequent primary 
  Ref. n Age 
(mean)
Benign 
disease
Malignant 
disease
Pancreatic 
adenocarcinoma
  Chen et al[6]     16    82.3   1     15     5
  Makary et al[7]   207 82 30   177   96
  Finlayson et al[8] 2915 NR   0 2915 NR
  Riall et al[9]   214 NR 50   164 NR
  Hardacre et al[3]     32 82   2     30   25
  Tani et al[2]     25    82.3   3     22   10
  Lee et al[10]     74    82.6 16     58   45
  Khan et al[11]     53 NR   0     53   53
  Stauffer et al[12]     32    82.1 11     21   18
  Hatzaras et al[13]     27    83.4   0     27   24
  Melis et al[14]     25 83   0     25   25
  Oguro et al[15]     22     81.5   0     22     8
  Turrini et al[16]     64 83   0     64   64
  Belyaev et al[17]     38 82 NR NR NR
  Beltrame et al[18]     23    82.6   1     22   20  
  Kinoshita et al[19]     26 82   0     26   26
  Total 3793    82.2     114 3641 419
 Table 1  Type of periampullary neoplasms
NR: Not reported.
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tumor (74.6% of malignant cases, n = 419), followed 
by periampullary carcinoma (11.6%, n = 65) and 
cholangiocarcinoma (6.6%, n = 37). Other malignant 
tumor types reported were neuroendocrine tumors, 
intraductal papillary mucinous neoplasms (IPMNs) with 
invasive carcinoma, and pancreatic secondary tumors. 
Among benign neoplasms (n = 64, 10.2%), the most 
frequent indications were benign or borderline IPMNs 
(n = 25, 39.1%), cystic neoplasms (20.3%, n = 13) 
and neuroendocrine tumors (9.4%, n = 6). A total of 
3793 resections were performed, with data on 751 
pancreatoduodenectomy, 90 distal pancreatectomy and 
24 total pancreatectomy (TP). A vascular resection was 
reported in 48 cases (Table 2). 
EARLY OUTCOME
Overall morbidity and mortality rates were 34.9% and 
13.2% respectively, with a mean length of hospital stay 
of 18 d (Table 3). Detailed information on specific type 
of postsurgical complications were available for 569 
patients. Most frequent complications were pancreatic 
fistula (12.1%, n = 69), delayed gastric emptying 
(10.9%, n = 62) and cardiopulmonary complications 
(9.3%, n = 53). Reoperations rate was 7.5% (Table 4). 
Four studies[2,8,9,11] focused on hospital discharge and the 
need for skilled nurse facilities after surgical resection. 
Finlayson et al[8], Riall et al[9] and Khan et al[11] observed 
a percentage of respectively 63.3%, 61.8% and 79% of 
resected patients who were discharged directly home, 
with or without home health care support. The other 
patients were discharged to health care facilities (nursing 
home, skilled care or other intermediate care facilities) 
or required other inpatient acute care hospitals. 
ADJUVANT THERAPY
Only few studies reported data on adjuvant therapy 
after pancreatic resections for cancer (Table 5). 
Kinoshita et al[19] reported 13 out of 26 resected patients 
(50%) who received adjuvant treatment. Six out of 13 
patients completed the planned adjuvant chemotherapy, 
which was discontinued in the other patients because 
of poor general conditions, chemotherapy-related 
adverse-events or postoperative recurrence. Beltrame 
et al[18] reported 30% of resected patients who received 
adjuvant treatment, while in the study by Turrini et 
al[16] the patients’ rate receiving postsurgical treatment 
was as low as 23.4%. Finally, Hardacre et al[3] reported 
10/25 patients resected for adenocarcinoma who were 
administered adjuvant chemotherapy. Specific survival 
outcome for patients receiving adjuvant treatment were 
not reported. 
SURVIVAL
Median overall survival was 17.6 mo. One-year and 
5-year survival rates were not always reported and 
varies among different series; at that point it is important 
to keep in mind that different reports consider different 
surgical indications. One-year survival rates range from 
50% to 75.7%, while 5-year survival rates range from 
0% to 46% (Table 5). When considering only those 
studies focusing on pancreatic adenocarcinoma, median 
overall survival is 15.4 mo. Melis et al[14] reported a 
1-year and 5-year survival rate of 68.2% and 4.5% 
respectively. Turrini et al[16] reported a 1-year survival 
rate of 75.7% while 5-year survival rate was 0%. 
  Ref. Type of surgical 
procedure
Vascular 
resections 
% (n)
ASA SCORE
PD DP TP 1-2 3-4
  Chen et al[6]   16   0   0 NR NR NR
  Makary et al[7] 197   0 10 2.4 (5) NR NR
  Finlayson et al[8] NR NR NR NR NR NR
  Riall et al[9] 155 48 NR NR NR NR
  Hardacre et al[3]   26   5   1 12.5 (4)   8   24
  Tani et al[2]   25   0   0 4 (1) NR NR
  Lee et al[10]   74   0   0 14.9 (11) NR NR
  Khan et al[11]   18 10   4 6.25 (2)   7   46
  Stauffer et al[12]   20   5   0 NR NR NR
  Hatzaras et al[13]   53   0   0 NR NR NR
  Melis et al[14]   25   0   0 4 (1)   7   17
  Oguro et al[15]   22   0   0 23 (5) 21     1
  Turrini et al[16]   56   8   0 11 (7) 37   23
  Belyaev et al[17]   27   3   8 NR NR NR
  Beltrame et al[18]   21   2   0 8.7 (2)   5   18
  Kinoshita et al[19]   16   9   1 39 (10) NR NR
  Total 751 90 24 85 129
Table 2  Type of surgical resections and American Society of 
Anesthesiologists score
PD: Pancreaticoduodenectomy; DP: Distal pancreatectmy; TP: Total 
pancreatectomy; NR: Not reported; ASA: American Society of Anesthesi-
ologists.
  Ref. Mortality 
% (n)
Morbidity 
% (n)
Mean length of 
stay (d)
  Chen et al[6] 13.0 (2) 51 (8) 25.0
  Makary et al[7] 4.0 (8) 53 (109) 11.0
  Finlayson et al[8] 15.5 (452) NR 20.4
  Riall et al[9] 11.4 (24) NR 15.0
  Hardacre et al[3] 0 66 (21) 11.0
  Tani et al[2] NR 44 (11) 25.0
  Lee et al[10] 5.4 (4) 47 (35) 10.5
  Khan et al[11] 2.0 (1) 51 (27) 13.5
  Stauffer et al[12] 0 50 (16) 13.3
  Hatzaras et al[13] 3.7 (1) 52 (14) 12.0
  Melis et al[14] 4.0 (1) 68 (17) 20.0
  Oguro et al[15] 4.5 (1) 27 (6) 31.5
  Turrini et al[16] 4.7 (3) 56 (36) 24.9
  Belyaev et al[17] 11.4 (4) NR 15.0
  Beltrame et al[18] 0 (0) 43 (10) 13.5
  Kinoshita et al[19] 0 (0) 8 (2)1 25.8
  Total 13.2 (501) 34.9 (306)2 18.0
Table 3  Perioperative outcomes after pancreatic resection
NR: Not reported. 1Clavien-Dindo classification ≥ III; 2Riall et al[9] 
excluded, because only severe complications were reported.
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PROGNOSTIC FACTORS
Six authors[9,10,13,15,16,19] examined clinical variables 
and risk factors that could be associated with poorer 
survival in octogenarian patients. Hatzaras et al[13] 
reported lymphovascular invasion as the only predictor 
of survival. Oguro et al[15] found that pancreatic cancer 
was an independent poor prognostic factor in the 
multivariate analysis with a hazard ratio of 4.398. Turrini 
et al[16] identified 4 independent prognostic indicators 
of overall survival: Venous invasion, arterial invasion, 
positive lymph nodes and adjuvant treatment. In their 
multivariate analysis, Kinoshita et al[19] indicated that 
distant metastasis and the conclusion of the planned 
adjuvant therapy were independent prognostic factors 
of surgical resection. Lee et al[10] reported female 
gender, non-caucasian race and positive lymph nodes 
as factors associated with shorter survival time in the 
multivariate model. In none of the aforementioned 
studies, age 80 or more resulted to be a significant 
predictor of long-term survival. On the contrary, Riall et 
al[9] in a population-based study used logistic regression 
models to assess the independent effect of age group 
on mortality. When compared with patients < 69 years 
of age, age group was an independent predictor of 
mortality after pancreatic resection. 
QUALITY OF LIFE AFTER RESECTION
Although quality of life (QoL) is an important aspect of 
surgical result, this point is not evaluated in most of the 
studies. Gerstenhaber et al[20] firstly assessed QoL after 
pancreaticoduodenectomy in 70 elderly patients (aged 
70 years and older). Fatigue was the most common 
symptom for the first 6 mo after surgery, but QoL 
quickly improved to normal scores. However, it has 
been reported that patients 80 years or older required 
discharge to a nursing facility more frequently when 
compared to younger patients[21]: This is obviously 
due to the need of rehabilitation program both in the 
physical activity and digestive function.
DISCUSSION
The higher incidence of morbidity, risk of mortality 
and of a prolonged recovery in an extended care 
facility following hospital discharge, made in past 
years pancreatic surgery a rare indication for older 
patients. The improved outcomes after pancreatic 
resections performed in high-volume centres have 
allowed to broaden the selection criteria for surgery 
and to include more elderly patients. The first study 
considering octogenarian patients and pancreatic surgery 
was published by Sohn et al[22]: Authors compared 
postoperative outcome of octogenarian patients 
undergoing pancreaticoduodenectomy with patients 
younger than 80 years, and reported similar morbidity 
and mortality rates in the two different age groups. This 
observation was then confirmed in other subsequent 
studies, showing similar results in postoperative outcome 
in elderly patients[2,7,11]. On the contrary, two large 
population-based studies[8,9] showed high mortality rates 
after pancreatic surgery in octogenarians with a high 
rate of discharge to health facilities. Sukharamwala et 
al[23] performed a systematic review and meta-analysis 
comparing the results of four studies[7,11,13,22] and showed 
that patients 80-years or older had a higher incidence 
of postoperative morality, morbidity and pneumonia in 
comparison to younger patients. A recent meta-analysis 
by Casadei et al[24], showed a higher postoperative 
mortality rate in patients 80 years or older when 
compared to younger patients. These conflicting results 
may have different possible explanations. First of all, it 
  Ref. Pancreatic 
Fistula
Delayed 
gastric 
emptying
Postpan-
createctomy 
haemorrhage
Reoperation 
rate % (n)
  Chen et al[6]   2   3   3 NR
  Makary et al[7] 21 32   0     5.6 (11)
  Finlayson et al[8] NR NR NR NR
  Riall et al[9] NR NR NR NR
  Hardacre et al[3]   3   4   5 22.0 (7)
  Tani et al[2]   1   6   0 NR
  Lee et al[10]   3 NR NR   5.4 (4)
  Khan et al[11]   6   9   5   1.9 (1)
  Stauffer et al[12] NR NR NR   6.2 (2)
  Hatzaras et al[13]   3   0 NR   4.0 (1)
  Melis et al[14] NR NR NR NR
  Oguro et al[15] 11   5   4   4.5 (1)
  Turrini et al[16] 10 NR 10 10.9 (7)
  Belyaev et al[17] NR NR NR 13.1 (5)
  Beltrame et al[18]   4   0   1 13.0 (3)
  Kinoshita et al[19]   5   3   1 NR
  Total 69 62 29     7.5 (43)
Table 4  Postoperative complications and reoperation rates
NR: Not reported.
  Ref. Adjuvant 
therapy % 
(NR)
Median 
overall 
survival
(mo)
1-yr survival 
rate (%)
5-yr 
survival 
rate (%)
  Chen et al[6] NR 17.6 NR NR
  Makary et al[7] NR 19 59.1 24.4
  Finlayson et al[8] NR NR NR 11.3
  Riall et al[9] NR NR NR NR
  Hardacre et al[3] 31.2 (10) 14.4 57.0 24.0
  Tani et al[2] NR NR NR NR
  Lee et al[10] NR 11.6 NR NR
  Khan et al[11] 22 13.5 NR NR
  Stauffer et al[12] NR NR 67.0 42.0
  Hatzaras et al[13] NR 33.3 NR 33.1
  Melis et al[14] NR 17.3 68.2  4.5
  Oguro et al[15] 0 (0) 13.0 NR 46.0
  Turrini et al[16] 23.4 (15) 30.0 75.7 0
  Belyaev et al[17] NR NR NR NR
  Beltrame et al[18] 30.0 (7) 19.0 NR NR
  Kinoshita et al[19] 50.0 (13) 12.4 50.0 NR
Table 5  Long-term results
NR: Not reported.
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has to be considered that the presence of an increased 
prevalence of preoperative comorbidities, represents 
a potential selection bias in those studies comparing 
outcome of elderly to younger patients. Therefore, 
preoperative studies play a major role in recognizing 
high-risk patients and in selecting the most appropriate 
treatment. The identification of modifiable preoperative 
risk factors for morbidity and mortality would improve 
the surgical outcome of patients[25]. Several scoring 
systems are available in the clinical practice to assess 
the surgical risk of old patients: Adult Comorbidity 
Evaluation-27 (ACE-27)[26], Charlson Comorbidity index[27] 
and G8 geriatric screening tool[28]. These tools allow a 
risk stratification in order to evaluate the impact of age 
in the surgical management of elderly patients. Old 
patients require a multidisciplinary evaluation (geriatric 
assessment) in order to identify those individuals who 
are at high-risk of complication[29]. Another reason of 
difference in postoperative outcome may be the hospital 
load for pancreatic resections. In fact, the importance 
of hospital volume for improving outcome after 
pancreatic surgery has already been demonstrated[30] 
and better prognosis after centralization of pancreatic 
cancer resection is reported[31]. Riall et al[9] reported 
a mortality rate following surgery in octogenarians 
nearly doubled at low-volume facilities compared 
to high-volume centres. Management of elderly 
patients requires a multidisciplinary evaluation prior 
to surgery in order to have a precise risk stratification 
and a selection of patients undergoing surgery. 
Moreover, postoperative care requires a specialized 
staff (surgeons, anaesthesiologists, interventional 
radiologists, endoscopists, etc.) and specialized facilities 
commonly available in high-volume centres. Finally, 
only few reports[3,16,18,19] in the literature reported the 
patients’ rate undergoing adjuvant treatment after 
surgery and their specific outcome. It is increasingly 
recognized that elderly patients are underrepresented 
in cancer trials and that elderly patients are less likely 
to receive adjuvant chemotherapy[32,33]. Reluctance to 
administer postoperative treatment is often based on 
the presence of comorbidities in elderly patients and by 
the perception that there is an increased risk of non-
cancer-related cause of death, limiting the overall benefit 
of adjuvant treatment. Nagrial et al[33] showed that this 
is not the case, being cancer the predominant cause 
of death in older patients. Given the role of adjuvant 
therapies in prolonging overall survival and delaying 
time to recurrence in resectable pancreatic cancer[34,35], 
the advancing age alone should not preclude the use of 
adjuvant treatment. Although these limitations, most 
Authors reported that overall survival after resection for 
pancreatic cancer in octogenarians is not statistically 
different from younger patients[18,21,36,37].
CONCLUSION
Although several authors say that major pancreatic 
surgery is safe and feasible in very old patients, the risk 
of postoperative complications and troubled outcome 
objectively exist, and may explain the reluctance to 
perform such complex operation in older patients[38]. 
To overcome any prejudice, a careful patient selection 
is fundamental to avoid or reduce postoperative 
mortality and morbidity. It seems reasonable to consider 
elderly patients with 2 or 3 ASA score, with a low 
rate of comorbidity and good performance status, as 
good candidate for surgical resection. Even if caution 
is recommended when treating elderly patients, the 
morbidity and mortality rates of octogenarians appear 
within the acceptable range for pancreatic surgery 
when performed at experienced centres. Geriatric 
assessment and centralization of pancreatic cancer 
are key to treatment decisions for patients 80 years 
and older. Survival after pancreatic resection appears 
similar in old and young patients, but we are lacking 
sufficient information about the quality of life of elderly 
pancreatectomized patients. Additionally, prospective 
studies are needed in order to determine the quality of 
life and long-term outcome in this subset of patients, 
because these features have to be considered in 
planning of the surgical treatment of octogenarians. 
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